Janssen Pharmaceuticals Inc.

09/13/2021 | Press release | Distributed by Public on 09/13/2021 23:25

Johnson & Johnson Ebola Vaccine Regimen Demonstrated Robust and Durable Immune Response in Adults and Children in Data Published in The Lancet Infectious Diseases

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.